NASDAQ: RIVN
Rivian Automotive, Inc. / DECIK 0001874178 · SIC 3711 · Motor Vehicles & Passenger Car Bodies
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.
Rivian CFO Claire McDonough resigns effective October 30; Derek Mulvey named Interim CFO
4 material changes detected. Sign up free to read the summary.
Rivian reports Q2 2026 revenue up 27% to $1.66B, turns gross profit positive, begins R2 deliveries
5 material changes detected. Sign up free to read the summary.
Partner
Trade RIVN commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
revenue $1.66B, net income -$833.0M. Rivian narrows Q2 loss 25% on R2 launch, equity raise, and regulatory-credit surge
5 material changes detected. Sign up free to read the summary.
Rivian raises $1.32B through 86.25M share offering at $15.50/share
3 material changes detected. Sign up free to read the summary.
Rivian prices 75M-share offering at $15.50, raising $1.14B net ($1.32B with overallotment)
7 material changes detected. Sign up free to read the summary.
Rivian reports preliminary Q2 2026 revenue of $1.55B-$1.65B, up 19-27% YoY
4 material changes detected. Sign up free to read the summary.
Rivian prices 75M-share follow-on offering at $18.63/share, raising $1.4B for DOE loan equity
4 material changes detected. Sign up free to read the summary.
Rivian beats Q2 delivery guidance, raises full-year outlook to 65,000-70,000 vehicles
3 material changes detected. Sign up free to read the summary.
Rivian shareholders express concern over executive pay with 33% opposition to say-on-pay
3 material changes detected. Sign up free to read the summary.
Rivian raises $300M from SMB, issuing 19.6M shares at $15.34 after hitting milestone
4 material changes detected. Sign up free to read the summary.
Rivian closes $1B Volkswagen investment, issues 62.9M shares at $15.90 after hitting milestones
4 material changes detected. Sign up free to read the summary.
Rivian secures $4B+ DOE loan amendment to fund 300K-unit Georgia EV plant
4 material changes detected. Sign up free to read the summary.
revenue $1.38B, net income -$416.0M. Rivian narrows Q1 loss 23.7%; R2 deliveries begin as litigation expands
5 material changes detected. Sign up free to read the summary.
Rivian reports Q1 2026 production and delivery figures
2 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 30, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
(in millions, except per share amounts)
| Description | Three months ended June 30, 2025 | Three months ended June 30, 2026 | Six months ended June 30, 2025 | Six months ended June 30, 2026 |
|---|---|---|---|---|
| Automotive | 927 | 1,143 | 1,849 | 2,051 |
| Software and services | 376 | 515 | 694 | 988 |
| Total revenues (Note 3) | 1,303 | 1,658 | 2,543 | 3,039 |
| Automotive | 1,262 | 1,179 | 2,092 | 2,149 |
| Software and services | 247 | 300 | 451 | 592 |
| Total cost of revenues | 1,509 | 1,479 | 2,543 | 2,741 |
| Gross profit | (206) | 179 | — | 298 |
| Operating expenses | ||||
| Research and development | 410 | 466 | 791 | 924 |
| Selling, general, and administrative | 498 | 549 | 978 | 1,091 |
| Total operating expenses | 908 | 1,015 | 1,769 | 2,015 |
| Loss from operations | (1,114) | (836) | (1,769) | (1,717) |
| Interest income | 72 | 48 | 153 | 98 |
| Interest expense (Note 8) | (69) | (68) | (141) | (133) |
| Other (expense) income, net | (2) | 18 | 105 | 496 |
| Loss before income taxes | (1,113) | (838) | (1,652) | (1,256) |
| Provision for income taxes | (2) | 1 | (4) | 3 |
| Net loss | (1,115) | (837) | (1,656) | (1,253) |
| Less: Net income (loss) attributable to noncontrolling interest | 2 | (4) | 6 | (4) |
| Net loss attributable to common stockholders | (1,117) | (833) | (1,662) | (1,249) |
| Net loss attributable to common stockholders, basic and diluted | (1,117) | (833) | (1,662) | (1,249) |
| Net loss per share attributable to Class A and Class B common stockholders, basic and diluted (Note 14) | (0.97) | (0.63) | (1.45) | (0.97) |
| Weighted-average common shares outstanding, basic and diluted (Note 14) | 1,155 | 1,325 | 1,146 | 1,287 |
Condensed Consolidated Balance Sheets (Unaudited)
(in millions, except per share amounts)
| Description | December 31, 2025 | June 30, 2026 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents (Note 5) | 3,579 | 3,592 |
| Short-term investments (Note 5) | 2,503 | 1,718 |
| Accounts receivable, net | 555 | 370 |
| Inventory (Note 6) | 1,594 | 1,661 |
| Other current assets | 361 | 277 |
| Total current assets | 8,592 | 7,618 |
| Property, plant, and equipment, net (Note 7) | 5,119 | 5,557 |
| Operating lease assets, net | 571 | 708 |
| Strategic investments (Note 2) | 119 | 697 |
| Other non-current assets | 463 | 560 |
| Total assets | 14,864 | 15,140 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 595 | 889 |
| Accrued liabilities (Note 9) | 1,438 | 1,085 |
| Current portion of deferred revenues, lease liabilities, and other liabilities (Note 9) | 1,660 | 1,646 |
| Total current liabilities | 3,693 | 3,620 |
| Long-term debt (Note 8) | 4,440 | 4,444 |
| Non-current lease liabilities | 551 | 693 |
| Other non-current liabilities (Note 9) | 1,586 | 1,256 |
| Total liabilities | 10,270 | 10,013 |
| Commitments and contingencies (Note 13) | ||
| Stockholders' equity: | ||
| Preferred stock, $0.001 par value; 10 shares authorized and 0 shares issued and outstanding as of December 31, 2025 and June 30, 2026 | — | — |
| Common stock, $0.001 par value; 5,258 and 5,258 shares authorized and 1,240 and 1,362 shares issued and outstanding as of December 31, 2025 and June 30, 2026, respectively (Note 14) | 1 | 1 |
| Additional paid-in capital | 31,508 | 33,305 |
| Accumulated deficit | (26,951) | (28,200) |
| Accumulated other comprehensive income | 8 | — |
| Noncontrolling interest | 28 | 21 |
| Total stockholders' equity | 4,594 | 5,127 |
| Total liabilities and stockholders' equity | 14,864 | 15,140 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in millions)
| Description | Six months ended June 30, 2025 | Six months ended June 30, 2026 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | (1,656) | (1,253) |
| Depreciation and amortization | 396 | 431 |
| Stock-based compensation expense | 377 | 433 |
| Gain on strategic investments | (101) | (506) |
| Other non-cash activities | 40 | 43 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | 189 | 191 |
| Inventory | 108 | (215) |
| Other assets | 38 | 78 |
| Accounts payable and accrued liabilities | 120 | 8 |
| Deferred revenues | 403 | (362) |
| Other liabilities | (38) | (38) |
| Net cash used in operating activities | (124) | (1,190) |
| Cash flows from investing activities: | ||
| Purchases of equity securities and short-term investments | (1,942) | (1,254) |
| Sales of equity securities and short-term investments | 101 | 22 |
| Maturities of short-term investments | 1,527 | 1,955 |
| Deconsolidation of Mind Robotics, Inc. | — | (114) |
| Capital expenditures | (800) | (734) |
| Net cash used in investing activities | (1,114) | (125) |
| Cash flows from financing activities: | ||
| Proceeds from stock-based compensation programs | 36 | 39 |
| Proceeds from issuance of capital stock | 750 | 1,300 |
| Proceeds from issuance of long-term debt | 1,250 | — |
| Repayments of long-term debt | (1,250) | — |
| Other financing activities | (36) | (9) |
| Net cash provided by financing activities | 750 | 1,330 |
| Effect of exchange rate changes on cash and cash equivalents | 6 | (2) |
| Net change in cash | (482) | 13 |
| Cash, cash equivalents, and restricted cash—Beginning of period | 5,294 | 3,579 |
| Cash, cash equivalents, and restricted cash—End of period | 4,812 | 3,592 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Capital expenditures included in liabilities | 452 | 492 |
| Capital stock issued to settle bonuses | 47 | 110 |
| Right-of-use assets obtained in exchange for operating lease liabilities | 134 | 203 |
Amounts as printed on the EDGAR/iXBRL face — (in millions, except per share amounts); (in millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗